Showing results (31-40 of 470) with videos related to

Sort By:
Pageof 47
The Lancet. Rheumatology|February 1, 2021
Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspectiveSarah L Mackie, Elisabeth Brouwer, Richard Conway, et al.
The Lancet. Rheumatology|January 24, 2022
Is social support associated with patient-reported outcomes after joint replacement? A systematic review and meta-analysisV Wylde, S K Kunutsor, E Lenguerrand, et al.
The Lancet. Rheumatology|August 11, 2022
Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trialJagdeep Nanchahal, Catherine Ball, Ines Rombach, et al.
The Lancet. Rheumatology|November 14, 2024
Understanding the multiple dimensions of ageing: 5Ms for the rheumatologistBjoern Buehring, Marloes van Onna, Elena Myasoedova, et al.
The Lancet. Rheumatology|November 2, 2024
Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label studyMikkel Østergaard, Mikael Boesen, Walter P Maksymowych, et al.
The Lancet. Rheumatology|November 11, 2024
Detection of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease using home monitoring in the Netherlands (DecreaSSc): a prospective, observational studyArthiha Velauthapillai, Catharina C Moor, Jeska K de Vries-Bouwstra, et al.
The Lancet. Rheumatology|November 25, 2024
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trialAnca D Askanase, David D'Cruz, Kenneth Kalunian, et al.
The Lancet. Rheumatology|July 19, 2024
Assessing the impact of health-care access on the severity of low back pain by country: a case study within the GBD frameworkYiFan Wu, Sarah Wulf Hanson, Garland Culbreth, et al.
The Lancet. Rheumatology|August 29, 2024
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trialsIoannis Parodis, Julius Lindblom, Roger A Levy, et al.
The Lancet. Rheumatology|August 17, 2024
Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysisMerlijn Wind, Juan J Fierro, Kitty W M Bloemenkamp, et al.
Pageof 47